These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 18322946)

  • 1. COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma.
    Liu XH; Lin J; Zhang SH; Zhang SM; Feitelson MA; Gao HJ; Zhu MH
    World J Gastroenterol; 2008 Mar; 14(9):1346-52. PubMed ID: 18322946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism analyses of hepatitis B virus X gene in hepatocellular carcinoma patients from southern China.
    Zhu P; Tan D; Peng Z; Liu F; Song L
    Acta Biochim Biophys Sin (Shanghai); 2007 Apr; 39(4):265-72. PubMed ID: 17417681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polymorphism of hepatitis B virus x gene in hepatocellular carcinoma patients and the biological effects of HBx gene with deletion varations on QSG7701 cells].
    Zhu PA; Tan DM; Peng ZT; Liu F; Song L
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):7-11. PubMed ID: 18226335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hepatitis B virus X gene variants between hepatocellular carcinoma tissues and pericarcinoma liver tissues in Eastern China.
    Wang D; Cai H; Yu WB; Yu L
    Int J Clin Exp Pathol; 2014; 7(9):5988-96. PubMed ID: 25337243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
    Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D
    Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells.
    Liu L; Li Y; Zhang S; Yu D; Zhu M
    Oncol Rep; 2012 Jan; 27(1):168-73. PubMed ID: 21956590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.
    Gouas DA; Villar S; Ortiz-Cuaran S; Legros P; Ferro G; Kirk GD; Lesi OA; Mendy M; Bah E; Friesen MD; Groopman J; Chemin I; Hainaut P
    Carcinogenesis; 2012 Jun; 33(6):1219-24. PubMed ID: 22759751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
    Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
    BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation.
    Zhang H; Shan CL; Li N; Zhang X; Zhang XZ; Xu FQ; Zhang S; Qiu LY; Ye LH; Zhang XD
    Acta Pharmacol Sin; 2008 Apr; 29(4):473-80. PubMed ID: 18358094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma.
    Zhang AY; Lai CL; Poon RT; Huang FY; Seto WK; Fung J; Wong DK; Yuen MF
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1638-45. PubMed ID: 26905957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection.
    Iavarone M; Trabut JB; Delpuech O; Carnot F; Colombo M; Kremsdorf D; Bréchot C; Thiers V
    J Hepatol; 2003 Aug; 39(2):253-61. PubMed ID: 12873823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of hepatitis B virus X gene (HBx) mutants in tissues of patients suffered from hepatocellular carcinoma in China.
    Wang Q; Zhang T; Ye L; Wang W; Zhang X
    Cancer Epidemiol; 2012 Aug; 36(4):369-74. PubMed ID: 22178505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas.
    Amaddeo G; Cao Q; Ladeiro Y; Imbeaud S; Nault JC; Jaoui D; Gaston Mathe Y; Laurent C; Laurent A; Bioulac-Sage P; Calderaro J; Zucman-Rossi J
    Gut; 2015 May; 64(5):820-9. PubMed ID: 25021421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxyl-terminal truncated HBx contributes to invasion and metastasis via deregulating metastasis suppressors in hepatocellular carcinoma.
    Li W; Li M; Liao D; Lu X; Gu X; Zhang Q; Zhang Z; Li H
    Oncotarget; 2016 Aug; 7(34):55110-55127. PubMed ID: 27391153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma.
    Chen GG; Li MY; Ho RL; Chak EC; Lau WY; Lai PB
    J Clin Virol; 2005 Sep; 34(1):7-12. PubMed ID: 16087118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
    Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
    Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.
    Ali A; Abdel-Hafiz H; Suhail M; Al-Mars A; Zakaria MK; Fatima K; Ahmad S; Azhar E; Chaudhary A; Qadri I
    World J Gastroenterol; 2014 Aug; 20(30):10238-48. PubMed ID: 25132741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.
    Li W; Chen G; Yu X; Shi Y; Peng M; Wei J
    Int J Clin Exp Pathol; 2013; 6(6):1076-85. PubMed ID: 23696925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
    Guo X; Jin Y; Qian G; Tu H
    J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.